Strategic Wealth Partners, Ltd.
Position in ROIV — Roivant Sciences Ltd.
CIK 1720777
INDEPENDENCE, OH
Position in ROIV
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$18,115
New position
Shares Held
654
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Strategic Wealth Partners, Ltd. holds $2,573,928 across 29 Biotechnology names. ROIV ranks #7 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,058 | $2,258,599 | |
| 2 | CMPX |
Compass Therapeutics, Inc.
|
16,825 | $89,004 | |
| 3 | ARGX |
Argenx SE
|
72 | $52,578 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52 | $40,177 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
607 | $28,874 | |
| 6 | TECH |
BIO-TECHNE Corp
|
351 | $18,343 | |
| 7 | ROIV |
Roivant Sciences Ltd.
This page
|
654 | $18,115 | |
| 8 | RNAC |
Cartesian Therapeutics, Inc.
|
2,029 | $12,478 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,115 | 654 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||